Osaic Holdings’s CollPlant Biotechnologies OPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-35
Closed -$120 – 8090
2026
Q2
$120 Hold
35
– – ﹤0.01% 7822
2026
Q1
$184 Buy
35
+1
+3% +$10 ﹤0.01% 7671
2025
Q4
$469 Hold
34
– – ﹤0.01% 7449
2025
Q3
$1.03K Hold
34
– – ﹤0.01% 7337
2025
Q2
$455 Sell
34
-6
-15% -$124 ﹤0.01% 7369
2025
Q1
$1.03K Buy
40
+21
+111% +$740 ﹤0.01% 6805
2024
Q4
$684 Sell
19
-18
-49% -$732 ﹤0.01% 6935
2024
Q3
$1.79K Buy
37
+17
+85% +$832 ﹤0.01% 6656
2024
Q2
$994 Buy
+20
New +$1.11K ﹤0.01% 6819
2022
Q2
– Sell
-25
Closed -$3K – 7364
2022
Q1
$3K Hold
25
– – ﹤0.01% 6713
2021
Q4
$4K Buy
+25
New +$4.46K ﹤0.01% 6734

Other funds holding OPHI

Osaic Holdings's OPHI Position: Q3 2026 in Review

Osaic Holdings sold out of CollPlant Biotechnologies (OPHI) in Q3 2026, closing a stake of 35 shares — an estimated $120 sold.

Osaic Holdings first reported a position in OPHI in Q4 2021 and held it in 11 quarters. The position peaked at $4K in Q4 2021. 8 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

  • Osaic Holdings reported no remaining CollPlant Biotechnologies position as of Q3 2026 after selling out during the quarter.
  • Osaic Holdings sold 35 CollPlant Biotechnologies shares in Q3 2026, an estimated $120.
  • Osaic Holdings first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 11 quarters.
  • Osaic Holdings's CollPlant Biotechnologies position peaked at $4K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.